1. MO-0137 A basis for combining atovaquone-mediated hypoxia alleviation with immunotherapy plus radiotherapy. (May 2022) Authors: Rodriguez-Berriguete, G.; Puliyadi, R.; Prevo, R.; Pugh, C.W.; Higgins, G.S. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0428 Development of DNA polymerase theta inhibitors as tumour specific radiosensitisers. (May 2022) Authors: Prevo, R.; Ranzani, M.; Puliyadi, R.; Rodriguez-Berriguete, G.; Robinson, H.; Rajendra, E.; Grinkevich, V.; Boursier, M.; Cicconi, A.; Piscitello, D.; Cerutti, A.; Majithiya, J.; Heald, R.; Stockley, M.; Smith, G.; Higgins, G. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP-0584: High throughput biological screens and their translation to new targets. (April 2015) Authors: McKenna, W.G.; Prevo, R.; Muschel, R.J.; Ashton, T.; Higgins, G.S. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗